A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma

  • Gurney, Howard (Primary Chief Investigator)
  • Chapman, Nicola (Research Coordinator)
  • Butala, Radhika (Research Coordinator)

Project: Other

Project Details

StatusFinished
Effective start/end date28/02/19 → 27/02/24